ALL, Childhood Clinical Trial
Official title:
Intraocular Pressure in Children With ALL Treated With High Dose Steroids
Childhood ALL patients are treated with high dose steroids. The study will follow the intraocular pressure of children treated in according to an AIEOP-BFM protocol, during the induction phase that will be compared to the pressure before treatment. Potential risk factors for developing elevated intraocular pressure will be estimated.
Children with ALL in Israel are treating according to the BFM ALL Protocol which contains high dose steroid therapy. One of the known side effects of high dose steroids is Intraocular hypertension, glaucoma, and even irreversible optic nerve injury. Early diagnosis of elevated intraocular pressure (IOP) and early therapeutic interventions might help to prevent future ocular damage. The purpose of this study is to determine the risk of developing evaluate Intraocular pressure during high dose steroid therapy. If elevated IOP will be common enough, we will try to corelate the risk of elevated IOP with potential risk factors, such as initial IOP, WBC at diagnosis, etc. Intraocular pressure will be measured by ophthalmologists using iCare devise: TONOPEN during general anesthesia at the day of diagnosis of ALL before steroid therapy initiation, and then after 15 and 33 days. Children with elevated IOP will continue ophthalmologists' follow up and treatment as necessary. All parents or patients' guardians will sign informed consent for participating in the study. The study group contains all newly diagnosed children with ALL in Schneider Children Medical Center. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06050850 -
A Healthy Weight Intervention for Family Stress During the Early Phases of ALL Treatment: NOURISH-ALL
|
||
| Recruiting |
NCT05487651 -
Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies
|
Phase 1 | |
| Recruiting |
NCT03571321 -
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
|
Phase 1 | |
| Terminated |
NCT01100658 -
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
|
N/A | |
| Recruiting |
NCT05763290 -
Childhood Cancer Survivors' Affective Response to Exercise
|
||
| Recruiting |
NCT06326463 -
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
|
Phase 1 | |
| Not yet recruiting |
NCT06389357 -
Return to School Adaptation Programme for Children With Cancer
|
N/A | |
| Recruiting |
NCT02879643 -
Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL
|
Phase 1 | |
| Active, not recruiting |
NCT03817320 -
PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
|
Phase 1/Phase 2 | |
| Terminated |
NCT04785547 -
ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT
|
Phase 2 | |
| Recruiting |
NCT05512169 -
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
|
||
| Completed |
NCT03627208 -
Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch
|
||
| Not yet recruiting |
NCT03889951 -
Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in Therapy
|